<?xml version="1.0" encoding="UTF-8"?>
<p>Idoxuridine is a thymidine (pyrimidine) analog that was identified as the first effective topical agent against HSV infection (
 <xref rid="B36" ref-type="bibr">Chou and Hong, 2014</xref>; 
 <xref rid="B200" ref-type="bibr">Wilhelmus, 2015</xref>), and was mainly used topically as an ointment for treating epithelial keratitis caused by HSV-1 infection of the corneal epithelium (
 <xref rid="B158" ref-type="bibr">Roozbahani and Hammersmith, 2018</xref>). However, its efficacy was clouded by its toxicity to the corneal epithelium of the eye and poor hydrosolubility and thus, has been currently replaced in favor of more effective, better-tolerated and less-toxic compounds (
 <xref rid="B200" ref-type="bibr">Wilhelmus, 2015</xref>).
</p>
